The previous page is sending you to https://presse.inserm.fr/en/good-tolerance-of-the-bnt162b2-vaccine-pfizer-biontech-and-good-efficacy-of-the-immune-response-against-sars-cov-2-variants-in-patients-with-systemic-lupus/60394/.

 If you do not want to visit that page, you can return to the previous page.